logo Technion
Technion logo
  • About
    • Leadership
    • Mission
    • History
    • Progress
      • Construction of Facilities
    • Why Technion?
  • Research
    • Cancer Types
      • Skin cancer
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Lung cancer
      • Kidney Cancer
      • Brain tumors
      • Pancreatic Cancer
      • Hematopoietic cancers
      • Lymphoma
    • Basic & Translational
      • Epigenetics
      • Stem Cell
      • MicroRNA
      • Metabolism
      • Tumor Microenvironment
      • Proteostasis
      • Cancer Immunology
    • Engineering & Clinical
    • Core
      • Core Metabolomics
      • Core Facility
    • Funding Opportunities
      • Core Service Support
  • Faculty
    • RTICC Core Faculty: Basic & Translational Research
    • Affiliated Faculty of Medicine: Clinical Cancer Research
    • Affiliated Engineering Faculties
    • Affiliated Faculty of Biology
  • Collaboration
    • Introduction
    • Collaborative Oncology Research Proposals
    • Guangdong-Technion Collaboration
    • Stipend Support in Cancer Research
  • Recruitment
    • Ongoing Recruitment focus
    • Post Doctoral Training
    • Open Positions
  • Upcoming
    • News
      • Incucyte quantitative high throughput live cell analysis system is here to stay
      • Research: Chemotherapy can cause metastasis
      • Ze’ev Ronai wins Lifetime Achievement Award from the Society for Melanoma Research
      • Researchers discover biological pathway that plays vital role in tumor development
    • Paper of the Month
    • Events
      • Symposium: RECENT PROGRESS IN CANCER RESEARCH AND DEVELOPMENT OF NOVEL THERAPIES
  • Support
    • Giving Opportunities
    • Make a Gift
  • Contact

News

  • 06 Sep 2020

    For the first time, a research at the RTICC and Rambam Medical Center finds: Cancer patients may not be at high risk for the Coronavirus disease

    A first-of-its-kind study examining the assumption that cancer patients are an at-risk group for COVID-19 finds that these patients do Read More

  • 20 Jan 2020

    Novel Insight in Pancreatic Cancer – from Ubiquitin Ligase Signaling to Metabolic Rewiring

    By Erez Hasnis, MD/PhD, Research Associate, Ze’ev Ronai’s Lab Cancer Initiation and Maintenance Program Sanford Bornham Prebys Medical Discovery Institute Read More

  • 28 Oct 2019

    31.10.2019 -Prof. Paolo Decuzzi Laboratory of Nanotechnology for Precision Medicine, “The Role of Mechano-Pharmocology in Treating Cancer and Chronic Inflammatory Diseases” –

    A Special Guest Seminar Prof. Paolo Decuzzi Laboratory of Nanotechnology for Precision Medicine   “The Role of Mechano-Pharmocology in Treating Read More

  • 29 May 2019

    הקמת בנק רקמות מוכוון סרטן

    כחלק מחיזוק הקשר בין מרכז רפואי רמב”ם ובין מרכז הסרטן, אנו מעוניינים להקים בנק רקמות ייעודי, לאיסוף סוגי דגימות שונות Read More

  • 23 May 2019

    תכנית אונקולוגיה רמב”ם/טכניון

    קול קורא, תכנית אונקולוגיה של רמב”ם/טכניון בשיתוף המרכז הטכניוני הבין תחומי לחקר הסרטן והמחלקה לאונקולוגיה, לטיפוח מצוינות אקדמית בתחום חקר Read More

  • 24 Jun 2018

    Paper of the Month – June 2018

    Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications By: Uri Barash et al. @ Israel Read More

  • 30 Mar 2017

    NEW – high throughput automatic whole slide scanner at the BCF Bioimaging center

    We are happy to inform you that our new high throughput automatic whole slide scanner, 3DHistech Pannoramic 250 Flash III, Read More

  • 25 Jan 2017

    Incucyte quantitative high throughput live cell analysis system is here to stay

    We are happy to inform you that the Incucyte ZOOM imaging system has been installed at the BCF Bioimaging Center Read More

  • 19 Dec 2016

    Research: Chemotherapy can cause metastasis

    New research at Israel’s Technion alarmingly reveals that the body acts to assist the tumor because it wrongly identifies chemotherapy Read More

  • 19 Dec 2016

    Ze’ev Ronai wins Lifetime Achievement Award from the Society for Melanoma Research

    Ze’ev Ronai, Ph.D., Co-Director of Technion Integrated Cancer Center, is the 2016 recipient of the Society for Melanoma Research’s Lifetime Achievement Read More

  • 19 Dec 2016

    Researchers discover biological pathway that plays vital role in tumor development

    An international team led by researchers from the Technion-Israel Institute of Technology’s Rappaport Faculty of Medicine and the Technion Integrated Read More

logo faculty of medicine
RTICC, The Ruth and Bruce Rappaport Faculty of Medicine
1 Efron St. Bat Galim, Haifa 3525433, Israel
  • Research Focus
  • Workshops
  • Recruitment Opportunities
Technion - TICC | Powered byFatfish